Your browser doesn't support javascript.
loading
Health insurance status and control of diabetes and coronary artery disease risk factors on enrollment into the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Grogan, Mary; Jenkins, Margaret; Sansing, Veronica V; MacGregor, Joan; Brooks, Maria Mori; Julien-Williams, Patricia; Amendola, Angela; Abbott, J Dawn.
Afiliación
  • Grogan M; The Department of Medicine, Rhode Island Hospital, Providence, Rhode Island (Ms Grogan, Dr Abbott)
  • Jenkins M; The Department of Medicine, Emory University School of Medicine, Atlanta, Georgia (Ms Jenkins)
  • Sansing VV; The Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania (Ms Sansing, Ms MacGregor, Dr Brooks)
  • MacGregor J; The Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania (Ms Sansing, Ms MacGregor, Dr Brooks)
  • Brooks MM; The Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania (Ms Sansing, Ms MacGregor, Dr Brooks)
  • Julien-Williams P; Georgetown University Medical Center, Washington, DC (Ms Julien-Williams)
  • Amendola A; New York University School of Medicine, New York, New York (Ms Amendola)
  • Abbott JD; The Department of Medicine, Rhode Island Hospital, Providence, Rhode Island (Ms Grogan, Dr Abbott)
Diabetes Educ ; 36(5): 774-83, 2010.
Article en En | MEDLINE | ID: mdl-20584997
PURPOSE: The purpose of this study was to examine measures of chronic disease severity and treatment according to insurance status in a clinical trial setting. METHODS: Baseline insurance status of 776 patients with type 2 diabetes and stable coronary artery disease (CAD) enrolled in the United States in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial was analyzed with regard to measures of metabolic and cardiovascular risk factor control. RESULTS: Compared with patients with private or public insurance, the uninsured were younger, more often female, and less often white non-Hispanic. Uninsured patients had the greatest burden of CAD. Patients with public insurance were treated with the greatest number of medications, had the greatest self-reported functional status, and the lowest mean glycosylated hemoglobin and low-density lipoprotein (LDL) cholesterol values. Overall, for 5 measured risk factor targets, the mean number above goal was 2.49 ± 1.18. After adjustment for demographic and clinical variables, insurance status was not associated with a difference in risk factor control. CONCLUSIONS: In the BARI 2D trial, we did not observe a difference in baseline cardiovascular risk factor control according to insurance status. An important observation, however, was that risk factor control overall was suboptimal, which highlights the difficulty in treating type 2 diabetes and CAD irrespective of insurance status.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad Coronaria / Diabetes Mellitus Tipo 2 / Seguro de Salud Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Diabetes Educ Año: 2010 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad Coronaria / Diabetes Mellitus Tipo 2 / Seguro de Salud Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Diabetes Educ Año: 2010 Tipo del documento: Article Pais de publicación: Estados Unidos